Hypofractionated stereotactic body radiation therapy (SBRT) in pediatric patients: preliminary toxicity results of a national prospective multicenter study.

Date publication

juillet 2021

Journal

The British journal of radiology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BERNIER-CHASTAGNER Valérie , Dr VIGNERON Céline

Tous les auteurs :
Di Perri D, Jouglar E, Blanc E, Ducassou A, Huchet A, Vigneron C, Escande A, Chapet S, Leseur J, Bernier V, Carrie C, Martin V, Claude L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34233469

Résumé

While hypofractionated stereotactic body radiotherapy (SBRT) has been largely adopted in the adult setting, its use remains limited in pediatric patients. This is due, among other factors, to fear of potential toxicities of hypofractionated regimens at a young age. In this context, we report the preliminary acute (<3 months from SBRT) and middle-term (3-24 months) toxicity results of a national prospective study investigating SBRT in pediatric patients.

Référence

Br J Radiol. 2021 Jul 8;:20210176